Researchers
Onsite and Same-Day
Healthy Control Programs
Healthy Samples On-Demand
We understand that your ability to produce reliable results is contingent on the quality of samples you receive—particularly for molecules with short half-lives in circulation. Our full-service healthy control programs give you a convenient and customizable way to collect the freshest possible healthy control biospecimens.
Onsite programs allow employees to participate as healthy controls with our blood donor program, whereas remote same-day collection and delivery are available within a 4-hour radius of research sites in select geographical locations.
Blood Donor Programs in Action
>90%
Fulfillment Rate
100+
Healthy Participant
Studies Completed
300+
Onsite Employee
Participants
135+
Same-Day Studies
Completed
Learn more about our nationwide community of healthy members interested in research participation.
Why Sanguine
We handle all pre-screening, informed consent, privacy, and regulatory requirements for the onsite and same-day programs we offer.
You designate an onsite sample collection room, and we handle the rest. See what an active onsite program journey looks like. Download Quick-Reference Guide
Convenient
Quick Turnaround Time
Customizable
Longitudinal Sampling
Match Control for Demographic Variables
Maximized Sample Viability
We Specialize in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 60,000 total members ready to advance science and medicine for the conditions they live with.
Get started with a program
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, International Conference on Harmonization (ICH) and Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.